Soluble antigen arrays provide increased efficacy and safety over free peptides for tolerogenic immunotherapy.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Soluble antigen arrays provide increased efficacy and safety over free peptides for tolerogenic immunotherapy.
- Published In:
- Frontiers in immunology, 15, 1258369 (2024)
- Authors:
- Firdessa-Fite, Rebuma, Johnson, Stephanie N, Bechi Genzano, Camillo, Leon, Martin A, Ku, Amy, Ocampo Gonzalez, Fernando A, Milner, Joshua D, Sestak, Joshua O, Berkland, Cory, Creusot, Remi J
- Database ID:
- RPEP-08202
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08202APA
Firdessa-Fite, Rebuma; Johnson, Stephanie N; Bechi Genzano, Camillo; Leon, Martin A; Ku, Amy; Ocampo Gonzalez, Fernando A; Milner, Joshua D; Sestak, Joshua O; Berkland, Cory; Creusot, Remi J. (2024). Soluble antigen arrays provide increased efficacy and safety over free peptides for tolerogenic immunotherapy.. Frontiers in immunology, 15, 1258369. https://doi.org/10.3389/fimmu.2024.1258369
MLA
Firdessa-Fite, Rebuma, et al. "Soluble antigen arrays provide increased efficacy and safety over free peptides for tolerogenic immunotherapy.." Frontiers in immunology, 2024. https://doi.org/10.3389/fimmu.2024.1258369
RethinkPeptides
RethinkPeptides Research Database. "Soluble antigen arrays provide increased efficacy and safety..." RPEP-08202. Retrieved from https://rethinkpeptides.com/research/firdessa-fite-2024-soluble-antigen-arrays-provide
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.